» Articles » PMID: 15750596

The Chemokine Receptor D6 Limits the Inflammatory Response in Vivo

Overview
Journal Nat Immunol
Date 2005 Mar 8
PMID 15750596
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

How the inflammatory response is initiated has been well defined but relatively little is known about how such responses are resolved. Here we show that the D6 chemokine receptor is involved in the post-inflammatory clearance of beta-chemokines from cutaneous sites. After induction of inflammation by phorbol esters, wild-type mice showed a transient inflammatory response. However, in D6-deficient mice, an excess concentration of residual chemokines caused a notable inflammatory pathology with similarities to human psoriasis. These results suggest that D6 is involved in the resolution of the cutaneous inflammatory response.

Citing Articles

The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice.

Russo R, Ryffel B Cells. 2025; 13(24).

PMID: 39768150 PMC: 11674266. DOI: 10.3390/cells13242058.


Identification of critical residues at the C-terminal tip of ACKR4 regulating chemokine internalization and βarrestin involvement.

Gerken O, Catone N, Legler D Cell Commun Signal. 2024; 22(1):576.

PMID: 39623381 PMC: 11610291. DOI: 10.1186/s12964-024-01961-8.


The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice.

Xia W, Eltrich N, Vielhauer V Front Immunol. 2024; 15:1377913.

PMID: 38799420 PMC: 11116673. DOI: 10.3389/fimmu.2024.1377913.


Atypical chemokine receptors in the immune system.

Comerford I, McColl S Nat Rev Immunol. 2024; 24(10):753-769.

PMID: 38714818 DOI: 10.1038/s41577-024-01025-5.


New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance.

Szpakowska M, DUonnolo G, Luis R, Bartolome A, Thelen M, Legler D Front Immunol. 2023; 14:1133394.

PMID: 37153591 PMC: 10157204. DOI: 10.3389/fimmu.2023.1133394.